← FDA Drug Approvals (Drugs@FDA)

BENDECTIN

NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1956-07-30

Drug application

FDA Application #
NDA010598
Application type
New Drug Application
Brand name
BENDECTIN
Generic name
Doxylamine Succinate
Active ingredients
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing status
Discontinued
Sponsor
SANOFI AVENTIS US
First approval
1956-07-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown